Connect with us

Hi, what are you looking for?

Jewish Business News


Kushner family withdraws from Phoenix acquisition

The Kushner family was unable to agree on terms with Delek Group.

"A Film Unfinished" New York Premiere - Arrivals


“Since the Kushner group was unable to reach agreement with Delek Group Ltd. (TASE: DLEKG) on the binding terms for acquiring control in The Phoenix Holdings Ltd. (TASE: PHOE1;PHOE5), the Kushner group has decided to withdraw the request submitted to the Commissioner of Insurance, Capital Markets, and Savings, ” parties on behalf of the Kushner family announced today.

In July 2014, the Kushner family, led by Jared Kushner, and Delek Group signed a non-binding letter of understanding for the sale of a 47% controlling share in Phoenix for $435 million (Phoenix’s equity, plus 5% annual interest up to the completion date for the deal). The exclusivity period agreed by the parties has since expired, and it was reported that the buyers were considering the addition of another investor to the deal.

The negotiations reached a dead end, however, and market sources predicted a month ago that the acquisition would not go through. The sources said that Delek Group would not agree to the Kushner family’s request for a 15% discount (more than NIS 250 million) on the acquisition price. In support of its request for a discount, the Kushner family cited the establishment of a workers’ committee at Phoenix, the burdensome regulation in the Israeli market, the findings in due diligence for Phoenix, and the current multiple at which the Phoenix share is traded on the Tel Aviv Stock Exchange (TASE).


Published by Globes [online], Israel business news –

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...